☆ 4.4 Meeting Abstract

IMPACT OF ELEXACAFTOR/TEZACAFTOR/yIVACAFTOR TRIPLE COMBINATION THERAPY ON HEALTH-RELATED QUALITY OF LIFE IN PEOPLE WITH CYSTIC FIBROSIS HOMOZYGOUS FOR F508DEL: RESULTS FROM A PHASE 3 CLINICAL STUDY

PEDIATRIC PULMONOLOGY (2020)

Add to Collection

Journal

PEDIATRIC PULMONOLOGY
Volume 55, Issue -, Pages S225-S225

Publisher

WILEY

Keywords

-

Categories

Pediatrics Respiratory System

Funding

  1. Vertex Pharmaceuticals Inc.

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.